Combined hormonal contraception and its effects on mood: a critical review

J. Schaffir, Brett L. Worly, T. Gur
{"title":"Combined hormonal contraception and its effects on mood: a critical review","authors":"J. Schaffir, Brett L. Worly, T. Gur","doi":"10.1080/13625187.2016.1217327","DOIUrl":null,"url":null,"abstract":"Abstract Objectives: Adverse mood changes are sometimes cited as a reason for discontinuing combined hormonal contraception (CHC). A systematic review of recent literature was undertaken to characterise the nature of these side effects and identify characteristics that might predispose women to such effects. Methods: A MEDLINE review of studies from the past 30 years that focused on CHC and mood was performed. Database search was supplemented with studies found through citations and references. Results: The research literature on this topic is limited by a lack of prospective studies, a variety of measurements of mood, and a consolidation of many disparate types of contraceptives studied together in a single cohort. Common themes that emerge from review of these papers include (1) most women using CHC demonstrate no effect or a beneficial effect on mood, with a low incidence of adverse effects; (2) contraceptives containing less androgenic progestins may have fewer adverse effects on mood; (3) continuous and perhaps non-oral dosing of CHC has the fewest mood effects; (4) women with underlying mood disorders may be predisposed to mood effects, but this may reflect factors related to choice of contraception rather than the mood disorder itself. Conclusion: Inconsistent research methods and lack of uniform assessments make it difficult to make strong conclusions about which CHC users are at risk for adverse mood effects. Until more prospective data is available, clinicians should recognise that such effects are infrequent and CHC may be prescribed with confidence.","PeriodicalId":22423,"journal":{"name":"The European Journal of Contraception & Reproductive Health Care","volume":"42 1","pages":"347 - 355"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"90","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European Journal of Contraception & Reproductive Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/13625187.2016.1217327","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 90

Abstract

Abstract Objectives: Adverse mood changes are sometimes cited as a reason for discontinuing combined hormonal contraception (CHC). A systematic review of recent literature was undertaken to characterise the nature of these side effects and identify characteristics that might predispose women to such effects. Methods: A MEDLINE review of studies from the past 30 years that focused on CHC and mood was performed. Database search was supplemented with studies found through citations and references. Results: The research literature on this topic is limited by a lack of prospective studies, a variety of measurements of mood, and a consolidation of many disparate types of contraceptives studied together in a single cohort. Common themes that emerge from review of these papers include (1) most women using CHC demonstrate no effect or a beneficial effect on mood, with a low incidence of adverse effects; (2) contraceptives containing less androgenic progestins may have fewer adverse effects on mood; (3) continuous and perhaps non-oral dosing of CHC has the fewest mood effects; (4) women with underlying mood disorders may be predisposed to mood effects, but this may reflect factors related to choice of contraception rather than the mood disorder itself. Conclusion: Inconsistent research methods and lack of uniform assessments make it difficult to make strong conclusions about which CHC users are at risk for adverse mood effects. Until more prospective data is available, clinicians should recognise that such effects are infrequent and CHC may be prescribed with confidence.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
联合激素避孕及其对情绪的影响:一项重要综述
目的:不良情绪变化有时被认为是停止联合激素避孕(CHC)的原因。对最近的文献进行了系统的回顾,以描述这些副作用的性质,并确定可能使妇女易受此类影响的特征。方法:MEDLINE回顾了过去30年来关注CHC和情绪的研究。数据库检索补充了通过引用和参考文献找到的研究。结果:关于这一主题的研究文献由于缺乏前瞻性研究,各种情绪测量,以及在单一队列中合并许多不同类型的避孕方法而受到限制。从这些论文的回顾中出现的共同主题包括(1)大多数使用CHC的女性对情绪没有影响或有益影响,不良反应的发生率较低;(2)含有较少雄激素孕激素的避孕药对情绪的不良影响较小;(3)持续或非口服给药CHC对情绪的影响最小;(4)有潜在情绪障碍的女性可能更容易受到情绪影响,但这可能反映了与避孕选择有关的因素,而不是情绪障碍本身。结论:不一致的研究方法和缺乏统一的评估使得很难对哪些CHC使用者有不良情绪影响的风险做出强有力的结论。在获得更多的前瞻性数据之前,临床医生应该认识到这种效果并不常见,可以放心地开CHC处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pain relief during intrauterine device placement in nulligravid women with both oral ketorolac and an analgesic: a double-blinded randomised trial Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil ‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents Oestrogens in oral contraception: considerations for tailoring prescription to women’s needs Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1